These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26161025)

  • 1. Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection.
    Lee NR; Jang JW; Kim HS; Yhim HY
    Korean J Intern Med; 2015 Jul; 30(4):550-3. PubMed ID: 26161025
    [No Abstract]   [Full Text] [Related]  

  • 2. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate.
    Ohnishi K; Sakai F; Kudoh S; Ohno R
    Leukemia; 2006 Jun; 20(6):1162-4. PubMed ID: 16598305
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor.
    Wang JP; Wang T; Huang MJ; Wang L; Kang L; Wu XJ
    Am J Clin Oncol; 2011 Jun; 34(3):314-6. PubMed ID: 20622646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].
    Sassa M; Kobayashi Y; Sugeno H; Iwadate M; Suzuki S; Endo Y; Nakamura I; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):937-41. PubMed ID: 23863741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib-induced interstitial lung disease and sunitinib-associated intra-tumour haemorrhage.
    Loong HH; Yeo W
    Hong Kong Med J; 2008 Dec; 14(6):495-8. PubMed ID: 19060352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Rectal Gastrointestinal Stromal Tumor(GIST)Treated with Imatinib Mesylate Neoadjuvant Therapy to Preserve the Anus].
    Kenno S; Inagaki M; Funakoshi T; Yanagida N; Akabane H; Nakano S; Sato K
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):981-984. PubMed ID: 30026427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib-Induced Interstitial Pneumonitis Successfully Switched to Nilotinib in a Patient with Prior History of Mycobacterium tuberculosis Infection.
    Luo ZB; Xu N; Huang XP; Ouyang GF
    Turk J Haematol; 2017 Dec; 34(4):362-364. PubMed ID: 28753128
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
    Turner J; Batus M; Leslie W; Coogan C; Saclarides TJ
    Am Surg; 2010 Aug; 76(8):E110-2. PubMed ID: 21513625
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
    Kaneko M; Nozawa H; Emoto S; Murono K; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Watanabe T
    Anticancer Res; 2017 Sep; 37(9):5155-5160. PubMed ID: 28870948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Just Another Flare of Ulcerative Colitis?
    Kennedy J; Satsangi J; Chapman TP
    Gastroenterology; 2020 Jun; 158(8):e11-e12. PubMed ID: 31945358
    [No Abstract]   [Full Text] [Related]  

  • 11. A successful approach to overcome imatinib-induced skin toxicity in a GIST patient.
    Desar IM; van Herpen CM; van Erp NP; Kaal SE; van de Kerkhof PC; van der Graaf WT
    Anticancer Drugs; 2016 Jul; 27(6):576-9. PubMed ID: 26982239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resection of an Advanced Rectal Gastrointestinal Stromal Tumor Following Neoadjuvant Chemotherapy].
    Seita K; Yoneyama F; Kimura K; Kato Y; Otsuji H; Kouno H
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):973-975. PubMed ID: 30026425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate].
    Nakashima S; Fujita Y; Matsuo H; Ariyoshi Y; Fukuda K; Fujiyama J; Masuyama M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1932-4. PubMed ID: 23267934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT).
    Yoo C; Ryu MH; Nam BH; Ryoo BY; Demetri GD; Kang YK
    Eur J Cancer; 2016 Jan; 52():201-8. PubMed ID: 26699729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation.
    Woźniak A; Rutkowski P; Sciot R; Ruka W; Michej W; Debiec-Rychter M
    Int J Cancer; 2008 May; 122(9):2160-4. PubMed ID: 18183595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib-induced irreversible interstitial lung disease: A case report.
    Zhang P; Huang J; Jin F; Pan J; Ouyang G
    Medicine (Baltimore); 2019 Feb; 98(8):e14402. PubMed ID: 30813141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib and liver toxicity.
    Haq MI; Nixon J; Stanley AJ
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Outcomes of Rectal Gastrointestinal Stromal Tumor in the Era of Imatinib.
    Emoto S; Akiyoshi T; Mukai T; Yamaguchi T; Nagasaki T; Konishi T; Fukunaga Y
    J Gastrointest Surg; 2021 Nov; 25(11):2963-2965. PubMed ID: 33948860
    [No Abstract]   [Full Text] [Related]  

  • 19. [A Case of Local Resection for Rectal GIST Following Neoadjuvant Imatinib Mesylate Treatment].
    Yoshioka Y; Tokoro T; Ushijima H; Daito K; Kawamura J; Ueda K; Hida J; Okuno K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1997-1999. PubMed ID: 29394846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.
    Farag S; Verschoor AJ; Bosma JW; Gelderblom H; Kerst JM; Sleijfer S; Steeghs N
    J Clin Pharmacol; 2015 Aug; 55(8):920-5. PubMed ID: 25810235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.